WINNING STRATEGIES WASHINGTON

Lobbying for NATIONAL FRAGILE X FOUNDATION · afssa

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · posted Apr 18, 2026

Lobbying activity 2

Health Issues

Legislation directly impacting disability and rare disease communities; Issues around the funding of rare disease research

Budget/Appropriations

Funding for Fragile X and related initiates

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.